• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

天然类胡萝卜素及其合成糖肽缀合物可抑制新型冠状病毒复制。

Natural Apocarotenoids and Their Synthetic Glycopeptide Conjugates Inhibit SARS-CoV-2 Replication.

作者信息

Bereczki Ilona, Papp Henrietta, Kuczmog Anett, Madai Mónika, Nagy Veronika, Agócs Attila, Batta Gyula, Milánkovits Márton, Ostorházi Eszter, Mitrović Ana, Kos Janko, Zsigmond Áron, Hajdú István, Lőrincz Zsolt, Bajusz Dávid, Keserű György Miklós, Hodek Jan, Weber Jan, Jakab Ferenc, Herczegh Pál, Borbás Anikó

机构信息

Department of Pharmaceutical Chemistry, University of Debrecen, Egyetem tér 1, H-4032 Debrecen, Hungary.

Szentágothai Research Centre, National Laboratory of Virology, Ifjúság útja 20, H-7624 Pécs, Hungary.

出版信息

Pharmaceuticals (Basel). 2021 Oct 30;14(11):1111. doi: 10.3390/ph14111111.

DOI:10.3390/ph14111111
PMID:34832893
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8619593/
Abstract

The protracted global COVID-19 pandemic urges the development of new drugs against the causative agent SARS-CoV-2. The clinically used glycopeptide antibiotic, teicoplanin, emerged as a potential antiviral, and its efficacy was improved with lipophilic modifications. This prompted us to prepare new lipophilic apocarotenoid conjugates of teicoplanin, its pseudoaglycone and the related ristocetin aglycone. Their antiviral effect was tested against SARS-CoV-2 in Vero E6 cells, using a cell viability assay and quantitative PCR of the viral RNA, confirming their micromolar inhibitory activity against viral replication. Interestingly, two of the parent apocarotenoids, bixin and β-apo-8'carotenoic acid, exerted remarkable anti-SARS-CoV-2 activity. Mechanistic studies involved cathepsin L and B, as well as the main protease 3CLPro, and the results were rationalized by computational studies. Glycopeptide conjugates show dual inhibitory action, while apocarotenoids have mostly cathepsin B and L affinity. Since teicoplanin is a marketed antibiotic and the natural bixin is an approved, cheap and widely used red colorant food additive, these readily available compounds and their conjugates as potential antivirals are worthy of further exploration.

摘要

旷日持久的全球新冠疫情促使人们研发针对病原体严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的新药。临床使用的糖肽类抗生素替考拉宁成为一种潜在的抗病毒药物,其疗效通过亲脂性修饰得到了提高。这促使我们制备替考拉宁、其假苷元和相关的瑞斯托菌素苷元的新型亲脂性类胡萝卜素缀合物。使用细胞活力测定法和病毒RNA定量PCR,在非洲绿猴肾细胞(Vero E6)中测试了它们对SARS-CoV-2的抗病毒作用,证实了它们对病毒复制具有微摩尔级的抑制活性。有趣的是,两种母体类胡萝卜素,即胭脂树橙和β-阿朴-8'-胡萝卜酸,表现出显著的抗SARS-CoV-2活性。机制研究涉及组织蛋白酶L和B以及主要蛋白酶3CLPro,计算研究对结果进行了合理化分析。糖肽缀合物表现出双重抑制作用,而类胡萝卜素主要与组织蛋白酶B和L具有亲和力。由于替考拉宁是一种上市抗生素,天然的胭脂树橙是一种经批准的、廉价且广泛使用的红色食用色素添加剂,这些容易获得的化合物及其缀合物作为潜在的抗病毒药物值得进一步探索。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92dc/8619593/58261f2b0be6/pharmaceuticals-14-01111-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92dc/8619593/dea0d66447ec/pharmaceuticals-14-01111-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92dc/8619593/aea355745da9/pharmaceuticals-14-01111-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92dc/8619593/ba58feb81d50/pharmaceuticals-14-01111-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92dc/8619593/01deb8fe7c22/pharmaceuticals-14-01111-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92dc/8619593/58261f2b0be6/pharmaceuticals-14-01111-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92dc/8619593/dea0d66447ec/pharmaceuticals-14-01111-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92dc/8619593/aea355745da9/pharmaceuticals-14-01111-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92dc/8619593/ba58feb81d50/pharmaceuticals-14-01111-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92dc/8619593/01deb8fe7c22/pharmaceuticals-14-01111-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92dc/8619593/58261f2b0be6/pharmaceuticals-14-01111-g005.jpg

相似文献

1
Natural Apocarotenoids and Their Synthetic Glycopeptide Conjugates Inhibit SARS-CoV-2 Replication.天然类胡萝卜素及其合成糖肽缀合物可抑制新型冠状病毒复制。
Pharmaceuticals (Basel). 2021 Oct 30;14(11):1111. doi: 10.3390/ph14111111.
2
Semisynthetic teicoplanin derivatives with dual antimicrobial activity against SARS-CoV-2 and multiresistant bacteria.具有抗 SARS-CoV-2 和多重耐药菌双重抗菌活性的半合成替考拉宁衍生物。
Sci Rep. 2022 Sep 26;12(1):16001. doi: 10.1038/s41598-022-20182-y.
3
Glycopeptide Antibiotic Teicoplanin Inhibits Cell Entry of SARS-CoV-2 by Suppressing the Proteolytic Activity of Cathepsin L.糖肽类抗生素替考拉宁通过抑制组织蛋白酶L的蛋白水解活性来抑制严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的细胞进入。
Front Microbiol. 2022 Apr 28;13:884034. doi: 10.3389/fmicb.2022.884034. eCollection 2022.
4
All-Trans Retinoic Acid Exhibits Antiviral Effect against SARS-CoV-2 by Inhibiting 3CLpro Activity.全反式维甲酸通过抑制 3CLpro 活性对 SARS-CoV-2 表现出抗病毒作用。
Viruses. 2021 Aug 23;13(8):1669. doi: 10.3390/v13081669.
5
Development of a Fluorescence-Based, High-Throughput SARS-CoV-2 3CL Reporter Assay.基于荧光的高通量 SARS-CoV-2 3CL 报告酶测定法的建立。
J Virol. 2020 Oct 27;94(22). doi: 10.1128/JVI.01265-20.
6
Rescue of SARS-CoV-2 from a Single Bacterial Artificial Chromosome.从单个细菌人工染色体中拯救 SARS-CoV-2。
mBio. 2020 Sep 25;11(5):e02168-20. doi: 10.1128/mBio.02168-20.
7
[Development of antiviral drugs based on inhibitors of the SARS-COV-2 main protease].基于新型冠状病毒主要蛋白酶抑制剂的抗病毒药物研发
Biomed Khim. 2021 May;67(3):259-267. doi: 10.18097/PBMC20216703259.
8
A Simplified Quantitative Real-Time PCR Assay for Monitoring SARS-CoV-2 Growth in Cell Culture.一种用于监测细胞培养中 SARS-CoV-2 生长的简化定量实时 PCR 检测方法。
mSphere. 2020 Sep 2;5(5):e00658-20. doi: 10.1128/mSphere.00658-20.
9
Identification of chymotrypsin-like protease inhibitors of SARS-CoV-2 integrated computational approach.基于整合计算方法鉴定 SARS-CoV-2 的糜蛋白酶样蛋白酶抑制剂。
J Biomol Struct Dyn. 2021 Apr;39(7):2607-2616. doi: 10.1080/07391102.2020.1751298. Epub 2020 Apr 13.
10
Peptidyl nitroalkene inhibitors of main protease rationalized by computational and crystallographic investigations as antivirals against SARS-CoV-2.通过计算和晶体学研究合理化设计的主要蛋白酶的肽基硝基烯烃抑制剂作为抗SARS-CoV-2病毒药物
Commun Chem. 2024 Jan 18;7(1):15. doi: 10.1038/s42004-024-01104-7.

引用本文的文献

1
A Fresh Look at the Normal Mode Analysis of Proteins: Introducing Allosteric Co-Vibrational Modes.蛋白质正常模式分析的新视角:引入变构共振动模式
JACS Au. 2024 Apr 2;4(4):1303-1309. doi: 10.1021/jacsau.4c00109. eCollection 2024 Apr 22.
2
Antibacterial Conjugates of Kanamycin A with Vancomycin and Eremomycin: Biological Activity and a New MS-Fragmentation Pattern of Cbz-Protected Amines.卡那霉素A与万古霉素和埃瑞霉素的抗菌缀合物:生物活性及Cbz保护胺的新型质谱裂解模式
Antibiotics (Basel). 2023 May 11;12(5):894. doi: 10.3390/antibiotics12050894.
3
Microbead-based extracorporeal immuno-affinity virus capture: a feasibility study to address the SARS-CoV-2 pandemic.

本文引用的文献

1
Recent advances in developing small-molecule inhibitors against SARS-CoV-2.开发针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的小分子抑制剂的最新进展。
Acta Pharm Sin B. 2022 Apr;12(4):1591-1623. doi: 10.1016/j.apsb.2021.06.016. Epub 2021 Jul 2.
2
Drug repurposing screens identify chemical entities for the development of COVID-19 interventions.药物重定位筛选可识别用于开发 COVID-19 干预措施的化学实体。
Nat Commun. 2021 Jun 3;12(1):3309. doi: 10.1038/s41467-021-23328-0.
3
Exploring protein hotspots by optimized fragment pharmacophores.
基于微珠的体外免疫亲和病毒捕获:应对 SARS-CoV-2 大流行的可行性研究。
Mikrochim Acta. 2023 Feb 18;190(3):95. doi: 10.1007/s00604-023-05671-9.
4
Semisynthetic teicoplanin derivatives with dual antimicrobial activity against SARS-CoV-2 and multiresistant bacteria.具有抗 SARS-CoV-2 和多重耐药菌双重抗菌活性的半合成替考拉宁衍生物。
Sci Rep. 2022 Sep 26;12(1):16001. doi: 10.1038/s41598-022-20182-y.
5
Methylene Blue Is a Nonspecific Protein-Protein Interaction Inhibitor with Potential for Repurposing as an Antiviral for COVID-19.亚甲蓝是一种非特异性蛋白质-蛋白质相互作用抑制剂,具有重新用作COVID-19抗病毒药物的潜力。
Pharmaceuticals (Basel). 2022 May 18;15(5):621. doi: 10.3390/ph15050621.
6
In silico evaluation of food-derived carotenoids against SARS-CoV-2 drug targets: Crocin is a promising dietary supplement candidate for COVID-19.基于计算机的食物源类胡萝卜素对 SARS-CoV-2 药物靶标的评估:藏红花酸是一种有前景的 COVID-19 膳食补充剂候选物。
J Food Biochem. 2022 Sep;46(9):e14219. doi: 10.1111/jfbc.14219. Epub 2022 May 11.
通过优化的片段药效团探索蛋白质热点。
Nat Commun. 2021 May 27;12(1):3201. doi: 10.1038/s41467-021-23443-y.
4
Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational docking.通过晶体筛选和计算对接鉴定到 SARS-CoV-2 的 Nsp3 结构域的片段结合。
Sci Adv. 2021 Apr 14;7(16). doi: 10.1126/sciadv.abf8711. Print 2021 Apr.
5
Emerging SARS-CoV-2 Variants and Impact in Global Vaccination Programs against SARS-CoV-2/COVID-19.新型严重急性呼吸综合征冠状病毒2(SARS-CoV-2)变体及其对全球严重急性呼吸综合征冠状病毒2/冠状病毒病(COVID-19)疫苗接种计划的影响
Vaccines (Basel). 2021 Mar 11;9(3):243. doi: 10.3390/vaccines9030243.
6
Cathepsin L plays a key role in SARS-CoV-2 infection in humans and humanized mice and is a promising target for new drug development.组织蛋白酶L在SARS-CoV-2感染人类和人源化小鼠过程中起关键作用,是新药研发的一个有前景的靶点。
Signal Transduct Target Ther. 2021 Mar 27;6(1):134. doi: 10.1038/s41392-021-00558-8.
7
Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7.SARS-CoV-2 变体 B.1.351 和 B.1.1.7 的抗体抗性。
Nature. 2021 May;593(7857):130-135. doi: 10.1038/s41586-021-03398-2. Epub 2021 Mar 8.
8
The role of teicoplanin in the treatment of SARS-CoV-2 infection: A retrospective study in critically ill COVID-19 patients (Tei-COVID study).替考拉宁在治疗 SARS-CoV-2 感染中的作用:一项对危重症 COVID-19 患者的回顾性研究(Tei-COVID 研究)。
J Med Virol. 2021 Jul;93(7):4319-4325. doi: 10.1002/jmv.26925. Epub 2021 Mar 26.
9
Mortality Benefit of Remdesivir in COVID-19: A Systematic Review and Meta-Analysis.瑞德西韦对COVID-19的死亡率益处:一项系统评价和荟萃分析。
Front Med (Lausanne). 2021 Jan 27;7:606429. doi: 10.3389/fmed.2020.606429. eCollection 2020.
10
Natural and Nature-Derived Products Targeting Human Coronaviruses.天然产物和天然衍生产物靶向人类冠状病毒。
Molecules. 2021 Jan 16;26(2):448. doi: 10.3390/molecules26020448.